Koyfin Home > Directory > Health Care > Abbott Laboratories > Debt Issued

Abbott Laboratories Debt Issued Chart (ABT)

Abbott Laboratories annual/quarterly Debt Issued from 2010 to 2020.
  • Abbott Laboratories Debt Issued for the quarter ending September 09, 2020 was $-27m a 6,729.63% decrease of -1,817m year over year
  • Abbott Laboratories Debt Issued for the last 12 months ending September 09, 2020 was $3,073m a 40.06% increase of 1,231m year over year
  • Abbott Laboratories Annual Debt Issued for 2019 was $1,842m a -117.64% decrease of -2,167m from 2018
  • Abbott Laboratories Annual Debt Issued for 2018 was $4,009m a -68.17% decrease of -2,733m from 2017
  • Abbott Laboratories Annual Debt Issued for 2017 was $6,742m a -121.51% decrease of -8,192m from 2016
Other Cash Flow Metrics:
  • Abbott Laboratories Cash Flow from Operations for the quarter ending September 09, 2018 was $2,183m a 8.15% increase of 178m year over year
  • Abbott Laboratories Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,647m a 6.17% increase of 102m year over year
  • Abbott Laboratories Total Revenue for the quarter ending December 12, 2018 was $7,765m a 4.83% increase of 375m year over year
View Chart On Koyfin

Quarterly ABT Debt Issued Data

09/2020$-27m
06/2020$1,259m
03/2020$51m
12/2019$1,790m
09/2019$12m
06/2019$27m
03/2019$13m
12/2018$-24m
09/2018$3,893m
06/2018$134m

Annual ABT Debt Issued Data

2019$1,842m
2018$4,009m
2017$6,742m
2016$14,934m
2015$2,485m
2014$1,343m
2013$2,095m
2012$15,484m
2011$1,000m
2010$4,000m